HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 290/4/R992    most recent 00363.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Zheng, H. Articles by Patel, K. P. Search for Related Content PubMed PubMed Citation Articles by Zheng, H. Articles by Patel, K. P.

NEUROHUMORAL CONTROL OF CARDIOVASCULAR FUNCTION

Blunted nitric oxide-mediated inhibition of sympathetic nerve activity within the paraventricular nucleus in diabetic rats

¹Departments of Cellular and Integrative Physiology and ²Pharmacology, University of Nebraska Medical Center, Omaha, Nebraska

Submitted 24 May 2005 ; accepted in final form 23 November 2005

Recent evidence suggests that a central mechanism may be contributing to the sympathetic abnormality in diabetes. Nitric oxide (NO) has been known as a neurotransmitter in the central nervous system. The goal of this study was to examine the role of the endogenous NO system of the paraventricular nucleus (PVN) in regulation of renal sympathetic nerve activity (RSNA) in streptozotocin (STZ)-induced diabetic rats. The change in number of NADPH-diaphorase-positive neurons [a marker for neuronal NO synthase (nNOS) activity] in the PVN was measured. Diabetic rats were found to have significantly fewer nNOS positive cells in the PVN than in the control group (120 ± 11 vs. 149 ± 13, P < 0.05). Using RT PCR, Western blotting and immunofluorescent staining, it was also found that nNOS mRNA expression and protein level in the PVN were significantly decreased in the diabetic rats. Furthermore, using an in vivo microdialysis technique, we found that there was a lower NO_x release from the PVN perfusates in rats with diabetes compared with the control rats (142 ± 33 nM vs. 228 ± 29 nM, P < 0.05). In -chloralose- and urethane-anesthetized rats, an inhibitor of NO synthase, L-NMMA, microinjected into the PVN produced a dose-dependent increase in RSNA, mean arterial pressure (MAP), and heart rate (HR) in both control and diabetic rats. These responses were significantly attenuated in rats with diabetes compared with control rats (RSNA: 11 ± 3% vs. 35 ± 3%, P < 0.05). On the other hand, an NO donor, sodium nitroprusside (SNP), microinjected into the PVN produced a dose-dependent decrease in RSNA, MAP, and HR in the control and diabetic rats. RSNA (17 ± 3%, vs. 41 ± 6%, P < 0.05) and MAP in response to SNP were significantly blunted in the diabetic group compared with the control group. In conclusion, these data indicate an altered NO mechanism in the PVN of diabetic rats. This altered mechanism may contribute to the increased renal sympathetic neural activity observed in diabetes.

neuronal nitric oxide synthase; neuromodulator; neurohumoral drive; renal sympathetic nerve activity

This article has been cited by other articles:

				D. D. Canabal, J. G. Potian, R. G. Duran, J. J. McArdle, and V. H. Routh Hyperglycemia impairs glucose and insulin regulation of nitric oxide production in glucose-inhibited neurons in the ventromedial hypothalamus Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R592 - R600. [Abstract] [Full Text] [PDF]

				M. B. Barnes and J. L. Beverly Nitric oxide's role in glucose homeostasis Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R590 - R591. [Full Text] [PDF]